This study is testing the safety of Radiocaine, an investigational diagnostic test given through an IV (intravenous injection). Radiocaine is designed to help doctors see and measure activity in voltage-gated sodium channels, which are important for how cells work. This study is looking for 6 healthy adults, aged 18 and older, who are willing to have ECGs (heart tests), imaging scans, blood samples, and complete self-assessments. The main goals are to see how much radiation you absorb and to track any side effects for up to 30 days. This information will help guide future studies on Radiocaine.

Study design

This is a Phase 1, single-center, open-label study involving 6 healthy adult volunteers. It is not blinded, meaning both you and the study team will know you are receiving Radiocaine.

What's involved

You would receive a single IV injection of Radiocaine, undergo PET/MR imaging over several hours, and provide blood and urine samples at specific times. You will also have safety checks, including vital signs and lab tests, and complete self-assessment rating scales.

Compensation

Not stated in the trial record.

Follow-up

Your radiation absorbed dose will be measured at 1 day, and adverse events (side effects) will be monitored for 30 days after receiving Radiocaine.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.